ShenKang injection suppresses kidney fibrosis and oxidative stress via transforming growth factor‐β/Smad3 signalling pathway in vivo and in vitro

Publisher: John Wiley & Sons Inc

E-ISSN: 2042-7158|67|8|1054-1065

ISSN: 0022-3573

Source: JOURNAL OF PHARMACY AND PHARMACOLOGY: AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCE, Vol.67, Iss.8, 2015-08, pp. : 1054-1065

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content